Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 02 April 2012 | By Ansis Helmanis,
A new manual for medicines intended for use by Brazil's National Health Service (NHS) has been prepared by the country's national regulatory agency, ANVISA. The Manual requires the labeling of such drugs to carry the non-proprietary name of the drug and to have the NHS seal on all drug packaging, blister packs, vials, and bottles. The labeling requirements are intended to encourage NHS medical professionals to prescribe using the generic name of the active ingredient of the product, rather than the brand name.
Read more:
Anvisa lança manual para rotulagem dos medicamentos do Ministério da Saúde
Tags: NHS, pharmaceutical, brazil, drug